Soros Fund Management - PLASMATECH BIOPHARMACEUTICAL ownership

PLASMATECH BIOPHARMACEUTICAL's ticker is PTBI and the CUSIP is 72754H109. A total of 15 filers reported holding PLASMATECH BIOPHARMACEUTICAL in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of PLASMATECH BIOPHARMACEUTICAL
ValueSharesWeighting
Q1 2015$785,000
-10.3%
250,0000.0%0.01%
-20.0%
Q4 2014$875,000250,0000.01%
Other shareholders
PLASMATECH BIOPHARMACEUTICAL shareholders Q4 2014
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 2,686,895$9,270,0001.22%
Perceptive Advisors 1,250,000$4,375,0000.37%
SABBY MANAGEMENT, LLC 990,595$3,467,0000.11%
EQUITEC SPECIALISTS, LLC 73,250$253,0000.06%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 372,374$1,285,0000.05%
Soros Fund Management 250,000$875,0000.01%
BANK OF AMERICA CORP /DE/ 228$1,0000.00%
WELLS FARGO & COMPANY/MN 200$1,0000.00%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 100$00.00%
Tower Research Capital LLC (TRC) 600$2,0000.00%
View complete list of PLASMATECH BIOPHARMACEUTICAL shareholders